Clinical Trial Update: Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA) [Phase 4]

View source ↗

Summary

This Phase 4 trial compares low-dose versus standard-dose atazanavir/ritonavir in HIV infection and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 4 | Status: COMPLETED